SCHEMBL30965339

SCHEMBL30965339

Cc1ccc(C2C(=O)Nc3cc(Cl)ccc32)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.38
TP53 P04637 2/20 0.38
POLB P06746 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
CACNB4 O00305 1/20 0.36
CACNA1A O00555 1/20 0.36
CACNA1G O43497 1/20 0.36
CACNG3 O60359 1/20 0.36
CACNA1F O60840 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNB3 P54284 1/20 0.36
CACNA2D1 P54289 1/20 0.36
CACNG7 P62955 1/20 0.36
CACNA1B Q00975 1/20 0.36
CACNA1D Q01668 1/20 0.36
CACNB1 Q02641 1/20 0.36
CACNG1 Q06432 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3966480 1.00 PGR (0.38) PGRTP53POLBPDE4APDE4B
SCHEMBL30965348 0.89 PGR (0.41) PGRTP53POLBPDE4APDE4B
SCHEMBL29242310 0.89 PGR (0.41) PGRTP53POLBPDE4APDE4B
SCHEMBL29242543 0.85 TP53 (0.40) PGRTP53POLBCACNB4CACNA1A
SCHEMBL3965995 0.85 CACNB4 (0.41) PGRTP53CACNB4CACNA1ACACNA1G
SCHEMBL29242294 0.83 PDE4A (0.36) TP53POLBPDE4APDE4BPDE4C
SCHEMBL30965338 0.83 PDE4A (0.36) TP53POLBPDE4APDE4BPDE4C
SCHEMBL3967430 0.82 LMNA (0.45) PGRTP53CACNB4CACNA1ACACNA1G
SCHEMBL3969144 0.81 TP53 (0.43) PGRTP53POLBCACNB4CACNA1A
SCHEMBL29242288 0.80 PBRM1 (0.43) PGRTP53POLBCACNB4CACNA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221565-A 3-Aryl indol-2-one compound with anticancer activity and application thereof in preparation of medicines for treating cancers 常州大学 2024-06-21 CN disclosed